Cadonilimab (anti-PD-1&CTLA4) is a targeting PD1/CTLA4 IgG1 scaffold Fc-engineered humanized antibody. Cadonilimab (anti-PD-1&CTLA4) can be used for researching metastatic cervical cancer.
Specification: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182868-SCI_11afd20a4ac7bf47ed9b3526edd3f2f1.pdf
- UPC:
- 51111736
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab182868-100μg
- CAS:
- 2394841-59-7
- Product Size:
- 100μg